Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 692

1.

Liver-enriched transcription factor expression relates to chronic hepatic failure in humans.

Guzman-Lepe J, Cervantes-Alvarez E, Collin de l'Hortet A, Wang Y, Mars WM, Oda Y, Bekki Y, Shimokawa M, Wang H, Yoshizumi T, Maehara Y, Bell A, Fox IJ, Takeishi K, Soto-Gutierrez A.

Hepatol Commun. 2018 Mar 23;2(5):582-594. doi: 10.1002/hep4.1172. eCollection 2018 May.

2.

AtPep3 is a hormone-like peptide that plays a role in the salinity stress tolerance of plants.

Nakaminami K, Okamoto M, Higuchi-Takeuchi M, Yoshizumi T, Yamaguchi Y, Fukao Y, Shimizu M, Ohashi C, Tanaka M, Matsui M, Shinozaki K, Seki M, Hanada K.

Proc Natl Acad Sci U S A. 2018 May 14. pii: 201719491. doi: 10.1073/pnas.1719491115. [Epub ahead of print]

PMID:
29760074
3.

Effect of herbal medicine daikenchuto on oral and enteral caloric intake after liver transplantation: A multicenter, randomized controlled trial.

Kaido T, Shinoda M, Inomata Y, Yagi T, Akamatsu N, Takada Y, Ohdan H, Shimamura T, Ogura Y, Eguchi S, Eguchi H, Ogata S, Yoshizumi T, Ikegami T, Yamamoto M, Morita S, Uemoto S.

Nutrition. 2018 Mar 20;54:68-75. doi: 10.1016/j.nut.2018.02.022. [Epub ahead of print]

PMID:
29747091
4.

Survival of syngeneic and allogeneic iPSC-derived neural precursors after spinal grafting in minipigs.

Strnadel J, Carromeu C, Bardy C, Navarro M, Platoshyn O, Glud AN, Marsala S, Kafka J, Miyanohara A, Kato T Jr, Tadokoro T, Hefferan MP, Kamizato K, Yoshizumi T, Juhas S, Juhasova J, Ho CS, Kheradmand T, Chen P, Bohaciakova D, Hruska-Plochan M, Todd AJ, Driscoll SP, Glenn TD, Pfaff SL, Klima J, Ciacci J, Curtis E, Gage FH, Bui J, Yamada K, Muotri AR, Marsala M.

Sci Transl Med. 2018 May 9;10(440). pii: eaam6651. doi: 10.1126/scitranslmed.aam6651.

PMID:
29743351
5.

Repression of Nitrogen Starvation Responses by Members of the Arabidopsis GARP-Type Transcription Factor NIGT1/HRS1 Subfamily.

Kiba T, Inaba J, Kudo T, Ueda N, Konishi M, Mitsuda N, Takiguchi Y, Kondou Y, Yoshizumi T, Ohme-Takagi M, Matsui M, Yano K, Yanagisawa S, Sakakibara H.

Plant Cell. 2018 Apr;30(4):925-945. doi: 10.1105/tpc.17.00810. Epub 2018 Apr 5.

6.

Time-dependent, bidirectional, anti- and pro-spinal hyper-reflexia and muscle spasticity effect after chronic spinal glycine transporter 2 (GlyT2) oligonucleotide-induced downregulation.

Kamizato K, Marsala S, Navarro M, Kakinohana M, Platoshyn O, Yoshizumi T, Lukacova N, Wancewicz E, Powers B, Mazur C, Marsala M.

Exp Neurol. 2018 Jul;305:66-75. doi: 10.1016/j.expneurol.2018.03.013. Epub 2018 Mar 30.

PMID:
29608917
7.

Selective Gene Delivery for Integrating Exogenous DNA into Plastid and Mitochondrial Genomes Using Peptide-DNA Complexes.

Yoshizumi T, Oikawa K, Chuah JA, Kodama Y, Numata K.

Biomacromolecules. 2018 May 14;19(5):1582-1591. doi: 10.1021/acs.biomac.8b00323. Epub 2018 Apr 5.

PMID:
29601191
8.

Rituximab Induction to Prevent the Recurrence of PSC After Liver Transplantation-The Lessons Learned From ABO-Incompatible Living Donor Liver Transplantation.

Yamada Y, Hoshino K, Fuchimoto Y, Matsubara K, Hibi T, Yagi H, Abe Y, Shinoda M, Kitago M, Obara H, Yagi T, Okajima H, Kaido T, Uemoto S, Suzuki T, Kubota K, Yoshizumi T, Maehara Y, Inomata Y, Kitagawa Y, Egawa H, Kuroda T.

Transplant Direct. 2018 Feb 2;4(2):e342. doi: 10.1097/TXD.0000000000000760. eCollection 2018 Feb.

9.

DOCK1 inhibition suppresses cancer cell invasion and macropinocytosis induced by self-activating Rac1P29S mutation.

Tomino T, Tajiri H, Tatsuguchi T, Shirai T, Oisaki K, Matsunaga S, Sanematsu F, Sakata D, Yoshizumi T, Maehara Y, Kanai M, Cote JF, Fukui Y, Uruno T.

Biochem Biophys Res Commun. 2018 Feb 26;497(1):298-304. doi: 10.1016/j.bbrc.2018.02.073. Epub 2018 Feb 9.

10.

Appropriate Use of Stents to Prevent Biliary Complications after Living Donor Liver Transplantation.

Ikegami T, Yoshizumi T, Soejima Y, Ohira M, Maehara Y.

J Am Coll Surg. 2018 Feb;226(2):201. doi: 10.1016/j.jamcollsurg.2017.10.009. No abstract available.

PMID:
29389377
11.

Surgery for Hepatocellular Carcinoma in Patients with Child-Pugh B Cirrhosis: Hepatic Resection Versus Living Donor Liver Transplantation.

Harimoto N, Yoshizumi T, Fujimoto Y, Motomura T, Mano Y, Toshima T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2018 Jan 25. doi: 10.1007/s00268-018-4493-1. [Epub ahead of print]

PMID:
29372372
12.

Hepatobiliary and Pancreatic: Pregnancy induced hepatic veno-occlusive disease requiring liver transplantation.

Harimoto N, Yugawa K, Ikegami T, Ohira M, Mano Y, Motomura T, Toshima T, Itoh S, Harada N, Soejima Y, Yoshizumi T, Maehara Y, Oda Y.

J Gastroenterol Hepatol. 2018 Jan;33(1):9. doi: 10.1111/jgh.13975. No abstract available.

PMID:
29284078
13.

Efficacy and safety of everolimus with reduced tacrolimus in living-donor liver transplant recipients: 12-month results of a randomized multicenter study.

Jeng LB, Lee SG, Soin AS, Lee WC, Suh KS, Joo DJ, Uemoto S, Joh J, Yoshizumi T, Yang HR, Song GW, Lopez P, Kochuparampil J, Sips C, Kaneko S, Levy G.

Am J Transplant. 2017 Dec 13. doi: 10.1111/ajt.14623. [Epub ahead of print]

PMID:
29237235
14.

Successful Recombinant Thrombomodulin Treatment for Thrombotic Microangiopathy After Liver Transplantation: A Case Report.

Motomura T, Yoshizumi T, Ohira M, Mano Y, Toshima T, Itoh S, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Transplant Proc. 2017 Dec;49(10):2409-2410. doi: 10.1016/j.transproceed.2017.09.014.

PMID:
29198692
15.

Predictors of Cure of Intrahepatic Cholangiocarcinoma After Hepatic Resection.

Tsukamoto M, Yamashita YI, Imai K, Umezaki N, Yamao T, Okabe H, Nakagawa S, Hashimoto D, Chikamoto A, Ishiko T, Yoshizumi T, Maehara Y, Baba H.

Anticancer Res. 2017 Dec;37(12):6971-6975.

PMID:
29187482
16.

Potential effect of recombinant thrombomodulin on ischemia-reperfusion liver injury in rats.

Kimura K, Yoshizumi T, Inokuchi S, Itoh S, Motomura T, Mano Y, Toshima T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Apr;48(5):391-396. doi: 10.1111/hepr.13005. Epub 2018 Jan 8.

PMID:
29168258
17.

Clinical Outcomes of Living Liver Transplantation According to the Presence of Sarcopenia as Defined by Skeletal Muscle Mass, Hand Grip, and Gait Speed.

Harimoto N, Yoshizumi T, Izumi T, Motomura T, Harada N, Itoh S, Ikegami T, Uchiyama H, Soejima Y, Nishie A, Kamishima T, Kusaba R, Shirabe K, Maehara Y.

Transplant Proc. 2017 Nov;49(9):2144-2152. doi: 10.1016/j.transproceed.2017.09.017.

PMID:
29149975
18.

Fibrinolysis in Living Donor Liver Transplantation Recipients Evaluated Using Thromboelastometry: Impact on Mortality.

Shimauchi T, Yamaura K, Higashi M, Abe K, Yoshizumi T, Hoka S.

Transplant Proc. 2017 Nov;49(9):2117-2121. doi: 10.1016/j.transproceed.2017.09.025.

PMID:
29149971
19.

MicroRNA-125b expression and intrahepatic metastasis are predictors for early recurrence after hepatocellular carcinoma resection.

Shimagaki T, Yoshizumi T, Harimoto N, Yoshio S, Naito Y, Yamamoto Y, Ochiya T, Yoshida Y, Kanto T, Maehara Y.

Hepatol Res. 2018 Mar;48(4):313-321. doi: 10.1111/hepr.12990. Epub 2017 Dec 5.

PMID:
28984009
20.

Impact of Splenic Volume and Splenectomy on Prognosis of Hepatocellular Carcinoma Within Milan Criteria After Curative Hepatectomy.

Takeishi K, Kawanaka H, Itoh S, Harimoto N, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y.

World J Surg. 2018 Apr;42(4):1120-1128. doi: 10.1007/s00268-017-4232-z.

PMID:
28920178
21.

Living donor liver transplantation for hepatocellular carcinoma: results of prospective patient selection by Kyushu University Criteria in 7 years.

Uchiyama H, Itoh S, Yoshizumi T, Ikegami T, Harimoto N, Soejima Y, Harada N, Morita K, Toshima T, Motomura T, Maehara Y.

HPB (Oxford). 2017 Dec;19(12):1082-1090. doi: 10.1016/j.hpb.2017.08.004. Epub 2017 Sep 7.

PMID:
28888776
22.

Asunaprevir and daclatasvir for recurrent hepatitis C after liver transplantation: A Japanese multicenter experience.

Ikegami T, Ueda Y, Akamatsu N, Ishiyama K, Goto R, Soyama A, Kuramitsu K, Honda M, Shinoda M, Yoshizumi T, Okajima H, Kitagawa Y, Inomata Y, Ku Y, Eguchi S, Taketomi A, Ohdan H, Kokudo N, Shimada M, Yanaga K, Furukawa H, Uemoto S, Maehara Y.

Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13109. Epub 2017 Sep 24.

PMID:
28881052
23.

Indication of living donor liver transplantation for septuagenarians from double equipoise theory.

Ikegami T, Yoshizumi T, Ohira M, Harada N, Soejima Y, Maehara Y.

Am J Transplant. 2018 Jan;18(1):278-279. doi: 10.1111/ajt.14446. Epub 2017 Aug 16. No abstract available.

PMID:
28742945
24.

The prevalence of transpancreatic common hepatic artery and coexisting variant anatomy.

Ishigami K, Nishie A, Asayama Y, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Yoshizumi T, Harimoto N, Ohtsuka T, Nakata K, Honda H.

Clin Anat. 2018 May;31(4):598-604. doi: 10.1002/ca.22957. Epub 2017 Dec 8.

PMID:
28726321
25.

Associations between antibody to hepatitis B core antigen positivity and outcomes in hepatocellular carcinoma patients undergoing hepatic resection.

Itoh S, Yoshizumi T, Tomino T, Nagatsu A, Motomura T, Harada N, Harimoto N, Ikegami T, Soejima Y, Maehara Y.

Hepatol Res. 2018 Feb;48(3):E155-E161. doi: 10.1111/hepr.12939. Epub 2017 Sep 28.

PMID:
28710825
26.

RLR-mediated antiviral innate immunity requires oxidative phosphorylation activity.

Yoshizumi T, Imamura H, Taku T, Kuroki T, Kawaguchi A, Ishikawa K, Nakada K, Koshiba T.

Sci Rep. 2017 Jul 14;7(1):5379. doi: 10.1038/s41598-017-05808-w.

27.

Impact and Prediction of Lymph Node Involvement in Patients with Intrahepatic Cholangiocarcinoma After Curative Resection.

Harada N, Yoshizumi T, Yamashita YI, Soejima Y, Ikegami T, Harimoto N, Itoh S, Maehara Y.

Anticancer Res. 2017 Jul;37(7):3763-3769.

PMID:
28668872
28.

Prognostic Significance of Preoperative Controlling Nutritional Status (CONUT) Score in Patients Undergoing Hepatic Resection for Hepatocellular Carcinoma.

Harimoto N, Yoshizumi T, Sakata K, Nagatsu A, Motomura T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

World J Surg. 2017 Nov;41(11):2805-2812. doi: 10.1007/s00268-017-4097-1.

PMID:
28653142
29.

Customization of laparoscopic gastric devascularization and splenectomy for gastric varices based on CT vascular anatomy.

Kawanaka H, Akahoshi T, Nagao Y, Kinjo N, Yoshida D, Matsumoto Y, Harimoto N, Itoh S, Yoshizumi T, Maehara Y.

Surg Endosc. 2018 Jan;32(1):114-126. doi: 10.1007/s00464-017-5646-2. Epub 2017 Jun 21.

PMID:
28639036
30.

Comparison of Radiation Exposure from Fixed Table Fluoroscopy to a Portable C-Arm During Ureteroscopy.

Cabrera FJ, Shin RH, Waisanen KM, Nguyen G, Wang C, Scales CD, Ferrandino MN, Preminger GM, Yoshizumi TT, Lipkin ME.

J Endourol. 2017 Sep;31(9):835-840. doi: 10.1089/end.2017.0240. Epub 2017 Jul 18.

PMID:
28622024
31.

Graft reduction using a powered stapler in pediatric living donor liver transplantation.

Yoshimaru K, Matsuura T, Kinoshita Y, Hayashida M, Takahashi Y, Yanagi Y, Harimoto N, Ikegami T, Uchiyama H, Yoshizumi T, Maehara Y, Taguchi T.

Pediatr Transplant. 2017 Sep;21(6). doi: 10.1111/petr.12985. Epub 2017 Jun 11.

PMID:
28603862
32.

The prognostic impact of programmed cell death ligand 1 and human leukocyte antigen class I in pancreatic cancer.

Imai D, Yoshizumi T, Okano S, Uchiyama H, Ikegami T, Harimoto N, Itoh S, Soejima Y, Aishima S, Oda Y, Maehara Y.

Cancer Med. 2017 Jul;6(7):1614-1626. doi: 10.1002/cam4.1087. Epub 2017 Jun 10.

33.

Hepatic artery reconstruction in living donor liver transplantation using surgical loupes: Achieving low rate of hepatic arterial thrombosis in 741 consecutive recipients-tips and tricks to overcome the poor hepatic arterial flow.

Ikegami T, Yoshizumi T, Uchiyama H, Soejima Y, Harada N, Maehara Y.

Liver Transpl. 2017 Aug;23(8):1081-1082. doi: 10.1002/lt.24798. Epub 2017 Jul 3. No abstract available.

PMID:
28590523
34.

Does apparent diffusion coefficient predict the degree of liver regeneration of donor and recipient after living donor liver transplantation?

Morita K, Nishie A, Asayama Y, Ishigami K, Ushijima Y, Takayama Y, Okamoto D, Fujita N, Ikegami T, Yoshizumi T, Shirabe K, Honda H.

Eur J Radiol. 2017 May;90:146-151. doi: 10.1016/j.ejrad.2017.02.041. Epub 2017 Mar 1.

PMID:
28583626
35.

In Situ Posterior Graft Segmentectomy for Large-for-Size Syndrome in Deceased Donor Liver Transplantation in Adults: A Case Report.

Nagatsu A, Yoshizumi T, Ikegami T, Harimoto N, Harada N, Soejima Y, Taketomi A, Maehara Y.

Transplant Proc. 2017 Jun;49(5):1199-1201. doi: 10.1016/j.transproceed.2017.03.036.

PMID:
28583557
36.

Duct-to-duct Biliary Reconstruction in Living-donor Liver Transplantation for Primary Sclerosing Cholangitis: Report of a Case.

Motomura T, Yoshizumi T, Wang H, Nagatsu A, Itoh S, Harada N, Harimoto N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

Transplant Proc. 2017 Jun;49(5):1196-1198. doi: 10.1016/j.transproceed.2017.03.069.

PMID:
28583556
37.

Mucinous nonneoplastic cyst of the pancreas: CT and MRI appearances.

Ishigami K, Nishie A, Mochidome N, Asayama Y, Ushijima Y, Kakihara D, Okamoto D, Fujita N, Ohtsuka T, Miyasaka Y, Hida T, Yoshizumi T, Honda H.

Abdom Radiol (NY). 2017 Dec;42(12):2827-2834. doi: 10.1007/s00261-017-1204-6.

PMID:
28567485
38.

Surgical Treatment and Outcome of Patients with De Novo Lung Cancer After Liver Transplantation.

Shoji F, Toyokawa G, Harada N, Itoh S, Harimoto N, Ikegami T, Okamoto T, Soejima Y, Yoshizumi T, Maehara Y.

Anticancer Res. 2017 May;37(5):2619-2623.

PMID:
28476836
39.

Coexpression of SALL4 with HDAC1 and/or HDAC2 is associated with underexpression of PTEN and poor prognosis in patients with hepatocellular carcinoma.

Wang H, Kohashi K, Yoshizumi T, Okumura Y, Tanaka Y, Shimokawa M, Iwasaki T, Aishima S, Maehara Y, Oda Y.

Hum Pathol. 2017 Jun;64:69-75. doi: 10.1016/j.humpath.2017.03.007. Epub 2017 Apr 12.

PMID:
28411180
40.

Preoperative Pancreatic Stiffness by Real-time Tissue Elastography to Predict Pancreatic Fistula After Pancreaticoduodenectomy.

Harada N, Yoshizumi T, Maeda T, Kayashima H, Ikegami T, Harimoto N, Itoh S, Maehara Y.

Anticancer Res. 2017 Apr;37(4):1909-1915.

PMID:
28373459
41.

Quasispecies of Hepatitis C Virus Participate in Cell-Specific Infectivity.

Fukuhara T, Yamamoto S, Ono C, Nakamura S, Motooka D, Mori H, Kurihara T, Sato A, Tamura T, Motomura T, Okamoto T, Imamura M, Ikegami T, Yoshizumi T, Soejima Y, Maehara Y, Chayama K, Matsuura Y.

Sci Rep. 2017 Mar 22;7:45228. doi: 10.1038/srep45228.

42.

Post-hepatectomy Refractory Ascites in Cirrhotic Patients with Hepatocellular Carcinoma: Risk Factor Analysis to Overcome this Problematic Complication.

Itoh S, Uchiyama H, Ikeda Y, Morita K, Harada N, Sugimachi K, Kawanaka H, Korenaga D, Yoshizumi T, Takenaka K, Maehara Y.

Anticancer Res. 2017 Mar;37(3):1381-1385.

PMID:
28314307
43.

Surgical Resection for Lymph Node Metastasis After Liver Transplantation for Hepatocellular Carcinoma.

Ikegami T, Yoshizumi T, Kawasaki J, Nagatsu A, Uchiyama H, Harada N, Harimoto N, Itoh S, Motomura T, Soejima Y, Maehara Y.

Anticancer Res. 2017 Feb;37(2):891-895.

PMID:
28179348
44.

Prognostic significance of combined albumin-bilirubin and tumor-node-metastasis staging system in patients who underwent hepatic resection for hepatocellular carcinoma.

Harimoto N, Yoshizumi T, Sakata K, Nagatsu A, Motomura T, Itoh S, Harada N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

Hepatol Res. 2017 Nov;47(12):1289-1298. doi: 10.1111/hepr.12868. Epub 2017 Mar 7.

PMID:
28169483
45.

Liver transplantation for cryptogenic liver failure caused by diffuse hepatic angiosarcoma: case report.

Yoshida Y, Yoshizumi T, Wang H, Sakata K, Shimokawa M, Kurihara T, Motomura T, Itoh S, Harada N, Harimoto N, Ikegami T, Uchiyama H, Soejima Y, Maehara Y.

Surg Case Rep. 2017 Dec;3(1):21. doi: 10.1186/s40792-017-0296-0. Epub 2017 Feb 1.

46.

Unique clinical courses of transfusion-transmitted hepatitis E in patients with immunosuppression.

Satake M, Matsubayashi K, Hoshi Y, Taira R, Furui Y, Kokudo N, Akamatsu N, Yoshizumi T, Ohkohchi N, Okamoto H, Miyoshi M, Tamura A, Fuse K, Tadokoro K.

Transfusion. 2017 Feb;57(2):280-288. doi: 10.1111/trf.13994. Epub 2017 Jan 31.

PMID:
28144952
47.

Treatment with sofosbuvir and ledipasvir without ribavirin for 12 weeks is highly effective for recurrent hepatitis C virus genotype 1b infection after living donor liver transplantation: a Japanese multicenter experience.

Ueda Y, Ikegami T, Akamatsu N, Soyama A, Shinoda M, Goto R, Okajima H, Yoshizumi T, Taketomi A, Kitagawa Y, Eguchi S, Kokudo N, Uemoto S, Maehara Y.

J Gastroenterol. 2017 Aug;52(8):986-991. doi: 10.1007/s00535-017-1310-9. Epub 2017 Jan 30.

PMID:
28138756
48.

In Situ Procurement of a Recipient's Portal Vein for a Right Lobe Liver Graft With Multiple Venous Orifices: A Case Report.

Soejima Y, Yoshizumi T, Ikegami T, Harimoto N, Harada N, Ito S, Motomura T, Uchiyama H, Maehara Y.

Transplant Proc. 2017 Jan - Feb;49(1):172-174. doi: 10.1016/j.transproceed.2016.10.028.

PMID:
28104129
49.

Surgical Resection of Giant Pheochromocytomas Arising Behind the Retrohepatic Inferior Vena Cava.

Soejima Y, Yoshizumi T, Ikegami T, Harimoto N, Ito S, Harada N, Motomura T, Nagatsu A, Ikeda T, Maehara Y.

Anticancer Res. 2017 Jan;37(1):277-280.

PMID:
28011503
50.

Hepatic stellate cells secreting WFA+ -M2BP: Its role in biological interactions with Kupffer cells.

Bekki Y, Yoshizumi T, Shimoda S, Itoh S, Harimoto N, Ikegami T, Kuno A, Narimatsu H, Shirabe K, Maehara Y.

J Gastroenterol Hepatol. 2017 Jul;32(7):1387-1393. doi: 10.1111/jgh.13708.

PMID:
28008658

Supplemental Content

Loading ...
Support Center